Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

BACKGROUND: The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central and Eastern Europe. The aim of this research was to provide a comprehensive description of country-specific health technology assessmen...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Orphanet J Rare Dis
Main Authors: Malinowski, Krzysztof Piotr, Kawalec, Paweł, Trąbka, Wojciech, Sowada, Christoph, Petrova, Guenka, Manova, Manoela, Savova, Alexandra, Draganić, Pero, Slabý, Juraj, Männik, Agnes, Márky, Kristóf, Rugaja, Zinta, Gulbinovic, Jolanta, Tesar, Tomas, Paveliu, Marian Sorin
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7545889/
https://ncbi.nlm.nih.gov/pubmed/33032634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01556-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki